CTRND Post-doctoral fellow, Jacob Ayers, Ph.D., under the direction of CTRND faculty Paramita Chakrabarty, Ph.D., Yona Levites, Ph.D., David Borchelt, Ph.D., and Todd Golde, M.D., Ph.D., has published a study in which he has demonstrated the potential of a genetic therapy in the treatment of ALS. The study was conducted with the support of the ALS Association.
Click HERE to read the entire ALS Association press release.
Click HERE to read the abstract on PubMed